Molecular mechanism of anti-SARS-CoV2 activity of Ashwagandha-derived withanolides.
A549 Cells
Antiviral Agents
/ chemistry
Cell Line
Cell Survival
/ drug effects
Computer Simulation
Down-Regulation
Gene Expression Regulation
/ drug effects
Humans
MCF-7 Cells
Models, Molecular
Molecular Dynamics Simulation
Plant Extracts
/ chemistry
Protein Conformation
SARS-CoV-2
/ drug effects
Serine Endopeptidases
/ chemistry
Viral Matrix Proteins
/ chemistry
Virus Internalization
/ drug effects
Withanolides
/ chemistry
COVID-19
Main protease (M(pro))
SARS-CoV-2
Transmembrane protease serine 2 (TMPRSS2)
Withanolides
Withanosides
Journal
International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578
Informations de publication
Date de publication:
01 Aug 2021
01 Aug 2021
Historique:
received:
28
12
2020
revised:
01
06
2021
accepted:
02
06
2021
pubmed:
13
6
2021
medline:
4
8
2021
entrez:
12
6
2021
Statut:
ppublish
Résumé
COVID-19 caused by SARS-CoV-2 corona virus has become a global pandemic. In the absence of drugs and vaccine, and premises of time, efforts and cost required for their development, natural resources such as herbs are anticipated to provide some help and may also offer a promising resource for drug development. Here, we have investigated the therapeutic prospective of Ashwagandha for the COVID-19 pandemic. Nine withanolides were tested in silico for their potential to target and inhibit (i) cell surface receptor protein (TMPRSS2) that is required for entry of virus to host cells and (ii) viral protein (the main protease M
Identifiants
pubmed: 34118289
pii: S0141-8130(21)01215-0
doi: 10.1016/j.ijbiomac.2021.06.015
pmc: PMC8188803
pii:
doi:
Substances chimiques
Antiviral Agents
0
Plant Extracts
0
Viral Matrix Proteins
0
Withanolides
0
membrane protein, SARS-CoV-2
0
Serine Endopeptidases
EC 3.4.21.-
TMPRSS2 protein, human
EC 3.4.21.-
Ashwagandha
V038D626IF
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
297-312Informations de copyright
Copyright © 2021. Published by Elsevier B.V.